THE SCHEDULE 13G

Company

4D Molecular Therapeutics, Inc.

Filed

July 6, 2021

Accession Number

0000921895-21-001775

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →